Ainos, (AIMDW)

$

9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
.
9
8
7
6
5
4
3
2
1
0
0
+$0.00 (+0.00%)Past DayToday's Volume:
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
9
8
7
6
5
4
3
2
1
0
0
,
9
8
7
6
5
4
3
2
1
0
0

Relative Strength Index (RSI)

- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.

- The RSI is calculated using the following formula:

RSI = 100 - (100 / (1 + RS))

Where RS is the ratio of the average gains to the average losses over a specified period.

- The default time period used is 14 days.

- RSI values range between 0 and 100.

RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)

RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)

RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.

About

Business overview of Ainos, (AIMDW)
Ainos Inc is engaged in developing biologics for the treatment of human and animal diseases. The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon-alpha that is administered in a proprietary low-dose oral form. Its product pipeline includes VELDONA Pet cytoprotein supplements for pets, VELDONA human therapeutics for clinical use, and telehealth-friendly POCTs powered by the AI Nose technology platform.

Key Insights

Critical company metrics and information

  • Total Outstanding Shares

    13.81 Million Shares

  • Total Employees

    46

  • Dividend

    No dividend

  • IPO Date

    August 5, 2022

  • SIC Description

    Pharmaceutical Preparations

  • Primary Exchange

    NASDAQ

  • Type

    Warrant

  • Phone Number

    858-869-2986

  • Address

    Ainos, inc., San diego, CA, 92108

  • Homepage

    https://www.ainos.com

Historical Stock Splits

Execution DateSplit Amount
No Historical Stock Splits

Cash Flow Statement

July 1, 2024 to September 30, 2024
MetricValue
Net Cash Flow From Financing Activities$-1.48 Million
Net Cash Flow From Investing Activities$-18,785.00
Net Cash Flow$-2.98 Million
Net Cash Flow From Financing Activities, Continuing$-1.48 Million
Net Cash Flow, Continuing$-2.98 Million
Net Cash Flow From Operating Activities, Continuing$-1.48 Million

Income Statement

July 1, 2024 to September 30, 2024
MetricValue
Selling, General, and Administrative Expenses$1.02 Million
Operating Income/Loss$-3.04 Million
Diluted Earnings Per Share$-0.33
Depreciation and Amortization$1.21 Million
Net Income/Loss Available To Common Stockholders, Basic$-3.70 Million
Income/Loss From Continuing Operations Before Tax$-3.70 Million

Balance Sheet

July 1, 2024 to September 30, 2024
MetricValue
Fixed Assets$649,063.00
Noncurrent Assets$25.72 Million
Intangible Assets$24.89 Million
Equity Attributable To Noncontrolling Interest$0.00
Liabilities And Equity$31.37 Million
Other Non-current Assets$183,229.00

Historical Dividends

Announcement DatePayment DateRecord DateAmountFrequency
No historical dividends
Boost your savings and earn 4.35% APY with a Marcus by Goldman Sachs savings account, a rate that's 8x the national averagewhen signing up with Financhle. No fees, no minimum deposits, backed by the financial expertise of Goldman Sachs. Terms apply.
Earnings CalendarNews ArticlesAbout UsPrivacy & Cookies Info

ⓒ 2025 Financhle. All Rights Reserved.